Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 197 entries
Sorted by: Best Match Show Resources per page
Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling.

Proceedings of the National Academy of Sciences of the United States of America

Pratt RB, Jacobsen AL, Percolla MI, De Guzman ME, Traugh CA, Tobin MF.
PMID: 34389676
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2104336118.

The xylem in plants is specialized to transport water, mechanically support the plant body, and store water and carbohydrates. Balancing these functions leads to trade-offs that are linked to xylem structure. We proposed a multivariate hypothesis regarding the main...

Cite
Pratt RB, Jacobsen AL, Percolla MI, et al. Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling. Proc Natl Acad Sci U S A. 2021;118(33)doi: 10.1073/pnas.2104336118.
Pratt, R. B., Jacobsen, A. L., Percolla, M. I., De Guzman, M. E., Traugh, C. A., & Tobin, M. F. (2021). Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling. Proceedings of the National Academy of Sciences of the United States of America, 118(33), . https://doi.org/10.1073/pnas.2104336118
Pratt, R B, et al. "Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling." Proceedings of the National Academy of Sciences of the United States of America vol. 118,33 (2021). doi: https://doi.org/10.1073/pnas.2104336118
Pratt RB, Jacobsen AL, Percolla MI, De Guzman ME, Traugh CA, Tobin MF. Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling. Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2104336118. PMID: 34389676; PMCID: PMC8379947.
Copy Download .nbib Format: NLM
Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

O'Shea JP, Augustijns P, Brandl M, Brayden DJ, Brouwers J, Griffin BT, Holm R, Jacobsen AC, Lennernäs H, Vinarov Z, O'Driscoll CM.
PMID: 34954051
Eur J Pharm Sci. 2021 Dec 22;170:106098. doi: 10.1016/j.ejps.2021.106098. Epub 2021 Dec 22.

The absorption of orally administered drug products is a complex, dynamic process, dependant on a range of biopharmaceutical properties; notably the aqueous solubility of a molecule, stability within the gastrointestinal tract (GIT) and permeability. From a regulatory perspective, the...

Cite
O'Shea JP, Augustijns P, Brandl M, et al. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. Eur J Pharm Sci. 2021;170:106098doi: 10.1016/j.ejps.2021.106098.
O'Shea, J. P., Augustijns, P., Brandl, M., Brayden, D. J., Brouwers, J., Griffin, B. T., Holm, R., Jacobsen, A. C., Lennernäs, H., Vinarov, Z., & O'Driscoll, C. M. (2021). Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 170106098. https://doi.org/10.1016/j.ejps.2021.106098
O'Shea, Joseph P, et al. "Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 170 (2021): 106098. doi: https://doi.org/10.1016/j.ejps.2021.106098
O'Shea JP, Augustijns P, Brandl M, Brayden DJ, Brouwers J, Griffin BT, Holm R, Jacobsen AC, Lennernäs H, Vinarov Z, O'Driscoll CM. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. Eur J Pharm Sci. 2021 Dec 22;170:106098. doi: 10.1016/j.ejps.2021.106098. Epub 2021 Dec 22. PMID: 34954051.
Copy Download .nbib Format: NLM
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis.

Blood cells, molecules & diseases

Kao RL, Jacobsen AA, Billington CJ, Yohe SL, Beckman AK, Vercellotti GM, Pearson DR.
PMID: 34864445
Blood Cells Mol Dis. 2021 Nov 30;93:102636. doi: 10.1016/j.bcmd.2021.102636. Epub 2021 Nov 30.

Vacuoles, E1, X-linked, autoimmunity, somatic (VEXAS) syndrome is characterized by a pathogenic mutation in UBA1, which leads to protean complications including autoimmunity and myelodysplasia. A 56-year-old man with steroid-dependent, later steroid-refractory cutaneous polyarteritis nodosa and Sweet syndrome developed recurrent...

Cite
Kao RL, Jacobsen AA, Billington CJ, et al. A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2021;93:102636doi: 10.1016/j.bcmd.2021.102636.
Kao, R. L., Jacobsen, A. A., Billington, C. J., Yohe, S. L., Beckman, A. K., Vercellotti, G. M., & Pearson, D. R. (2021). A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood cells, molecules & diseases, 93102636. https://doi.org/10.1016/j.bcmd.2021.102636
Kao, Roy L, et al. "A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis." Blood cells, molecules & diseases vol. 93 (2021): 102636. doi: https://doi.org/10.1016/j.bcmd.2021.102636
Kao RL, Jacobsen AA, Billington CJ, Yohe SL, Beckman AK, Vercellotti GM, Pearson DR. A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2021 Nov 30;93:102636. doi: 10.1016/j.bcmd.2021.102636. Epub 2021 Nov 30. PMID: 34864445.
Copy Download .nbib Format: NLM
Genotoxicity of multi-walled carbon nanotube reference materials in mammalian cells and animals.

Mutation research. Reviews in mutation research

Møller P, Wils RS, Di Ianni E, Gutierrez CAT, Roursgaard M, Jacobsen NR.
PMID: 34893158
Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108393. doi: 10.1016/j.mrrev.2021.108393. Epub 2021 Aug 21.

Carbon nanotubes (CNTs) were the first nanomaterials to be evaluated by the International Agency for Research on Cancer (IARC). The categorization as possibly carcinogenic agent to humans was only applicable to multi-walled carbon nanotubes called MWCNT-7. Other types of...

Cite
Møller P, Wils RS, Di Ianni E, et al. Genotoxicity of multi-walled carbon nanotube reference materials in mammalian cells and animals. Mutat Res Rev Mutat Res. 2021;788:108393doi: 10.1016/j.mrrev.2021.108393.
Møller, P., Wils, R. S., Di Ianni, E., Gutierrez, C. A. T., Roursgaard, M., & Jacobsen, N. R. (2021). Genotoxicity of multi-walled carbon nanotube reference materials in mammalian cells and animals. Mutation research. Reviews in mutation research, 788108393. https://doi.org/10.1016/j.mrrev.2021.108393
Møller, Peter, et al. "Genotoxicity of multi-walled carbon nanotube reference materials in mammalian cells and animals." Mutation research. Reviews in mutation research vol. 788 (2021): 108393. doi: https://doi.org/10.1016/j.mrrev.2021.108393
Møller P, Wils RS, Di Ianni E, Gutierrez CAT, Roursgaard M, Jacobsen NR. Genotoxicity of multi-walled carbon nanotube reference materials in mammalian cells and animals. Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108393. doi: 10.1016/j.mrrev.2021.108393. Epub 2021 Aug 21. PMID: 34893158.
Copy Download .nbib Format: NLM
Impact of Lighting Assessment and Optimization on Participation and Quality of Life in Individuals with Vision Loss.

Occupational therapy in health care

Øien TB, Jacobsen AM, Tødten ST, Russotti TØ, Smaakjaer P, Rasmussen RS.
PMID: 34971349
Occup Ther Health Care. 2021 Dec 31;1-18. doi: 10.1080/07380577.2021.2020388. Epub 2021 Dec 31.

This pilot study was designed to investigate the effects of a holistic lighting intervention on the quality of life for individuals with low vision. Sixty participants (44 women; median age 69 years) with visual impairment received lighting interventions, including...

Cite
Øien TB, Jacobsen AM, Tødten ST, et al. Impact of Lighting Assessment and Optimization on Participation and Quality of Life in Individuals with Vision Loss. Occup Ther Health Care. 2021;1-18doi: 10.1080/07380577.2021.2020388.
Øien, T. B., Jacobsen, A. M., Tødten, S. T., Russotti, T. �. �., Smaakjaer, P., & Rasmussen, R. S. (2021). Impact of Lighting Assessment and Optimization on Participation and Quality of Life in Individuals with Vision Loss. Occupational therapy in health care, 1-18. https://doi.org/10.1080/07380577.2021.2020388
Øien, T B, et al. "Impact of Lighting Assessment and Optimization on Participation and Quality of Life in Individuals with Vision Loss." Occupational therapy in health care vol. (2021): 1-18. doi: https://doi.org/10.1080/07380577.2021.2020388
Øien TB, Jacobsen AM, Tødten ST, Russotti TØ, Smaakjaer P, Rasmussen RS. Impact of Lighting Assessment and Optimization on Participation and Quality of Life in Individuals with Vision Loss. Occup Ther Health Care. 2021 Dec 31;1-18. doi: 10.1080/07380577.2021.2020388. Epub 2021 Dec 31. PMID: 34971349.
Copy Download .nbib Format: NLM
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.

World journal of urology

D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF.
PMID: 34370078
World J Urol. 2021 Dec;39(12):4345-4354. doi: 10.1007/s00345-021-03793-4. Epub 2021 Aug 09.

PURPOSE: To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).MATERIALS AND METHODS: We analyzed data from 1105 patients with MIBC. Patients age was evaluated as continuous variable and stratified...

Cite
D'Andrea D, Black PC, Zargar H, et al. Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2021;39(12):4345-4354doi: 10.1007/s00345-021-03793-4.
D'Andrea, D., Black, P. C., Zargar, H., Zargar-Shoshtari, K., Soria, F., Fairey, A. S., Mertens, L. S., Dinney, C. P., Mir, M. C., Krabbe, L. M., Cookson, M. S., Jacobsen, N. E., Montgomery, J. S., Vasdev, N., Yu, E. Y., Xylinas, E., Campain, N. J., Kassouf, W., Dall'Era, M. A., Seah, J. A., Ercole, C. E., Horenblas, S., Sridhar, S. S., McGrath, J. S., Aning, J., Wright, J. L., Thorpe, A. C., Morgan, T. M., Holzbeierlein, J. M., Bivalacqua, T. J., North, S., Barocas, D. A., Lotan, Y., Grivas, P., Stephenson, A. J., Shah, J. B., van Rhijn, B. W., Daneshmand, S., Spiess, P. E., & Shariat, S. F. (2021). Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology, 39(12), 4345-4354. https://doi.org/10.1007/s00345-021-03793-4
D'Andrea, David, et al. "Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer." World journal of urology vol. 39,12 (2021): 4345-4354. doi: https://doi.org/10.1007/s00345-021-03793-4
D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2021 Dec;39(12):4345-4354. doi: 10.1007/s00345-021-03793-4. Epub 2021 Aug 09. PMID: 34370078; PMCID: PMC8602146.
Copy Download .nbib Format: NLM
Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease.

Bone reports

Jacobsen AA, Bressendorff I, Nordholm A, Egstrand S, Jørgensen NR, Klausen TW, Olgaard K, Hansen D.
PMID: 34584906
Bone Rep. 2021 Sep 16;15:101130. doi: 10.1016/j.bonr.2021.101130. eCollection 2021 Dec.

Increasing levels of magnesium in blood are associated with reduced risk of cardiovascular disease in chronic kidney disease (CKD). Magnesium supplementation may reduce the progression of vascular calcification in CKD. The diurnal pattern and effect of fasting on magnesium...

Cite
Jacobsen AA, Bressendorff I, Nordholm A, et al. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease. Bone Rep. 2021;15:101130doi: 10.1016/j.bonr.2021.101130.
Jacobsen, A. A., Bressendorff, I., Nordholm, A., Egstrand, S., Jørgensen, N. R., Klausen, T. W., Olgaard, K., & Hansen, D. (2021). Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease. Bone reports, 15101130. https://doi.org/10.1016/j.bonr.2021.101130
Jacobsen, Alexanndra A, et al. "Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease." Bone reports vol. 15 (2021): 101130. doi: https://doi.org/10.1016/j.bonr.2021.101130
Jacobsen AA, Bressendorff I, Nordholm A, Egstrand S, Jørgensen NR, Klausen TW, Olgaard K, Hansen D. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease. Bone Rep. 2021 Sep 16;15:101130. doi: 10.1016/j.bonr.2021.101130. eCollection 2021 Dec. PMID: 34584906; PMCID: PMC8453182.
Copy Download .nbib Format: NLM
Towards FAIR nanosafety data.

Nature nanotechnology

Jeliazkova N, Apostolova MD, Andreoli C, Barone F, Barrick A, Battistelli C, Bossa C, Botea-Petcu A, Châtel A, De Angelis I, Dusinska M, El Yamani N, Gheorghe D, Giusti A, Gómez-Fernández P, Grafström R, Gromelski M, Jacobsen NR, Jeliazkov V, Jensen KA, Kochev N, Kohonen P, Manier N, Mariussen E, Mech A, Navas JM, Paskaleva V, Precupas A, Puzyn T, Rasmussen K, Ritchie P, Llopis IR, Rundén-Pran E, Sandu R, Shandilya N, Tanasescu S, Haase A, Nymark P.
PMID: 34017099
Nat Nanotechnol. 2021 Jun;16(6):644-654. doi: 10.1038/s41565-021-00911-6. Epub 2021 May 20.

Nanotechnology is a key enabling technology with billions of euros in global investment from public funding, which include large collaborative projects that have investigated environmental and health safety aspects of nanomaterials, but the reuse of accumulated data is clearly...

Cite
Jeliazkova N, Apostolova MD, Andreoli C, et al. Towards FAIR nanosafety data. Nat Nanotechnol. 2021;16(6):644-654doi: 10.1038/s41565-021-00911-6.
Jeliazkova, N., Apostolova, M. D., Andreoli, C., Barone, F., Barrick, A., Battistelli, C., Bossa, C., Botea-Petcu, A., Châtel, A., De Angelis, I., Dusinska, M., El Yamani, N., Gheorghe, D., Giusti, A., Gómez-Fernández, P., Grafström, R., Gromelski, M., Jacobsen, N. R., Jeliazkov, V., Jensen, K. A., Kochev, N., Kohonen, P., Manier, N., Mariussen, E., Mech, A., Navas, J. M., Paskaleva, V., Precupas, A., Puzyn, T., Rasmussen, K., Ritchie, P., Llopis, I. R., Rundén-Pran, E., Sandu, R., Shandilya, N., Tanasescu, S., Haase, A., & Nymark, P. (2021). Towards FAIR nanosafety data. Nature nanotechnology, 16(6), 644-654. https://doi.org/10.1038/s41565-021-00911-6
Jeliazkova, Nina, et al. "Towards FAIR nanosafety data." Nature nanotechnology vol. 16,6 (2021): 644-654. doi: https://doi.org/10.1038/s41565-021-00911-6
Jeliazkova N, Apostolova MD, Andreoli C, Barone F, Barrick A, Battistelli C, Bossa C, Botea-Petcu A, Châtel A, De Angelis I, Dusinska M, El Yamani N, Gheorghe D, Giusti A, Gómez-Fernández P, Grafström R, Gromelski M, Jacobsen NR, Jeliazkov V, Jensen KA, Kochev N, Kohonen P, Manier N, Mariussen E, Mech A, Navas JM, Paskaleva V, Precupas A, Puzyn T, Rasmussen K, Ritchie P, Llopis IR, Rundén-Pran E, Sandu R, Shandilya N, Tanasescu S, Haase A, Nymark P. Towards FAIR nanosafety data. Nat Nanotechnol. 2021 Jun;16(6):644-654. doi: 10.1038/s41565-021-00911-6. Epub 2021 May 20. PMID: 34017099.
Copy Download .nbib Format: NLM
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.

Lancet (London, England)

Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, Harris RA, Hutton D, Jacobsen N, Joyce K, Kaminski R, Libri V, Middleditch A, McCullagh L, Moran E, Phillipson A, Price E, Ryan J, Thirard R, Todd R, Snape MD, Tucker D, Williams RL, Nguyen-Van-Tam JS, Finn A, Rogers CA.
PMID: 34774197
Lancet. 2021 Nov 11; doi: 10.1016/S0140-6736(21)02329-1. Epub 2021 Nov 11.

BACKGROUND: Concomitant administration of COVID-19 and influenza vaccines could reduce burden on health-care systems. We aimed to assess the safety of concomitant administration of ChAdOx1 or BNT162b2 plus an age-appropriate influenza vaccine.METHODS: In this multicentre, randomised, controlled, phase 4...

Cite
Lazarus R, Baos S, Cappel-Porter H, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;doi: 10.1016/S0140-6736(21)02329-1.
Lazarus, R., Baos, S., Cappel-Porter, H., Carson-Stevens, A., Clout, M., Culliford, L., Emmett, S. R., Garstang, J., Gbadamoshi, L., Hallis, B., Harris, R. A., Hutton, D., Jacobsen, N., Joyce, K., Kaminski, R., Libri, V., Middleditch, A., McCullagh, L., Moran, E., Phillipson, A., Price, E., Ryan, J., Thirard, R., Todd, R., Snape, M. D., Tucker, D., Williams, R. L., Nguyen-Van-Tam, J. S., Finn, A., Rogers, C. A. (2021). Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet (London, England), . https://doi.org/10.1016/S0140-6736(21)02329-1
Lazarus, Rajeka, et al. "Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial." Lancet (London, England) vol. (2021). doi: https://doi.org/10.1016/S0140-6736(21)02329-1
Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, Harris RA, Hutton D, Jacobsen N, Joyce K, Kaminski R, Libri V, Middleditch A, McCullagh L, Moran E, Phillipson A, Price E, Ryan J, Thirard R, Todd R, Snape MD, Tucker D, Williams RL, Nguyen-Van-Tam JS, Finn A, Rogers CA. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021 Nov 11; doi: 10.1016/S0140-6736(21)02329-1. Epub 2021 Nov 11. PMID: 34774197; PMCID: PMC8585490.
Copy Download .nbib Format: NLM
Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications.

PloS one

Sugulle M, Halldórsdóttir E, Kvile J, Berntzen LSD, Jacobsen AF.
PMID: 34784382
PLoS One. 2021 Nov 16;16(11):e0259926. doi: 10.1371/journal.pone.0259926. eCollection 2021.

BACKGROUND: Midpelvic vacuum extractions are controversial due to reports of increased risk of maternal and perinatal morbidity and high failure rates. Prospective studies of attempted midpelvic vacuum outcomes are scarce. Our main aims were to assess frequency, failure rates,...

Cite
Sugulle M, Halldórsdóttir E, Kvile J, et al. Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications. PLoS One. 2021;16(11):e0259926doi: 10.1371/journal.pone.0259926.
Sugulle, M., Halldórsdóttir, E., Kvile, J., Berntzen, L. S. D., & Jacobsen, A. F. (2021). Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications. PloS one, 16(11), e0259926. https://doi.org/10.1371/journal.pone.0259926
Sugulle, Meryam, et al. "Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications." PloS one vol. 16,11 (2021): e0259926. doi: https://doi.org/10.1371/journal.pone.0259926
Sugulle M, Halldórsdóttir E, Kvile J, Berntzen LSD, Jacobsen AF. Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications. PLoS One. 2021 Nov 16;16(11):e0259926. doi: 10.1371/journal.pone.0259926. eCollection 2021. PMID: 34784382; PMCID: PMC8594828.
Copy Download .nbib Format: NLM
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.

World journal of urology

D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF.
PMID: 34370078
World J Urol. 2021 Dec;39(12):4345-4354. doi: 10.1007/s00345-021-03793-4. Epub 2021 Aug 09.

PURPOSE: To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).MATERIALS AND METHODS: We analyzed data from 1105 patients with MIBC. Patients age was evaluated as continuous variable and stratified...

Cite
D'Andrea D, Black PC, Zargar H, et al. Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2021;39(12):4345-4354doi: 10.1007/s00345-021-03793-4.
D'Andrea, D., Black, P. C., Zargar, H., Zargar-Shoshtari, K., Soria, F., Fairey, A. S., Mertens, L. S., Dinney, C. P., Mir, M. C., Krabbe, L. M., Cookson, M. S., Jacobsen, N. E., Montgomery, J. S., Vasdev, N., Yu, E. Y., Xylinas, E., Campain, N. J., Kassouf, W., Dall'Era, M. A., Seah, J. A., Ercole, C. E., Horenblas, S., Sridhar, S. S., McGrath, J. S., Aning, J., Wright, J. L., Thorpe, A. C., Morgan, T. M., Holzbeierlein, J. M., Bivalacqua, T. J., North, S., Barocas, D. A., Lotan, Y., Grivas, P., Stephenson, A. J., Shah, J. B., van Rhijn, B. W., Daneshmand, S., Spiess, P. E., & Shariat, S. F. (2021). Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology, 39(12), 4345-4354. https://doi.org/10.1007/s00345-021-03793-4
D'Andrea, David, et al. "Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer." World journal of urology vol. 39,12 (2021): 4345-4354. doi: https://doi.org/10.1007/s00345-021-03793-4
D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2021 Dec;39(12):4345-4354. doi: 10.1007/s00345-021-03793-4. Epub 2021 Aug 09. PMID: 34370078; PMCID: PMC8602146.
Copy Download .nbib Format: NLM
Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway - a cross-sectional study.

Ethnicity & health

Borgen I, Garnweidner-Holme LM, Jacobsen AF, Fayyad S, Cvancarova Småstuen M, Lukasse M.
PMID: 31416352
Ethn Health. 2022 Jan;27(1):209-222. doi: 10.1080/13557858.2019.1655530. Epub 2019 Aug 16.

No abstract available.

Cite
Borgen I, Garnweidner-Holme LM, Jacobsen AF, et al. Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway - a cross-sectional study. Ethn Health. 2019;27(1):209-222doi: 10.1080/13557858.2019.1655530.
Borgen, I., Garnweidner-Holme, L. M., Jacobsen, A. F., Fayyad, S., Cvancarova Småstuen, M., & Lukasse, M. (2022). Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway - a cross-sectional study. Ethnicity & health, 27(1), 209-222. https://doi.org/10.1080/13557858.2019.1655530
Borgen, Iren, et al. "Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway - a cross-sectional study." Ethnicity & health vol. 27,1 (2022): 209-222. doi: https://doi.org/10.1080/13557858.2019.1655530
Borgen I, Garnweidner-Holme LM, Jacobsen AF, Fayyad S, Cvancarova Småstuen M, Lukasse M. Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway - a cross-sectional study. Ethn Health. 2022 Jan;27(1):209-222. doi: 10.1080/13557858.2019.1655530. Epub 2019 Aug 16. PMID: 31416352.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 197 entries